In prostatic cancer cells (PC3), Ferrando et al. (2011) found that the overexpression of HO-1 caused the downregulation of several pro-inflammatory and angiogenic factors (NF-κB, VEGF-A, VEGF-C). Here, HMOX1 is linked to prostate carcinoma.